School of Nursing, University of Rochester, Rochester, New York.
Now with School of Nursing, University of Texas at Austin, Austin.
JAMA Netw Open. 2021 Dec 1;4(12):e2137492. doi: 10.1001/jamanetworkopen.2021.37492.
Long-term effectiveness of a peer-led asthma self-management program in improving asthma outcomes in adolescents living in urban areas has not been established.
To determine the long-term effects of a peer-led program on asthma control, quality of life, and asthma management among predominantly racial and ethnic minority adolescents living in urban areas.
DESIGN, SETTING, AND PARTICIPANTS: A parallel-group, randomized clinical trial was conducted in 2015 to 2019 in 3 metropolitan cities in the US: Buffalo, New York; Baltimore, Maryland; and Memphis, Tennessee. Adolescents aged 12 to 17 years old with persistent asthma were recruited mainly through clinical practices and schools. Participants were followed-up for 15 months after the intervention. Double-blinding was achieved for baseline. Data analysis was performed from June 2019 to June 2020.
The intervention group received a peer-led asthma self-management program; the control group received the identical program led by adult health care professionals. Peer leaders made follow-up contacts every other month for 12 months.
The primary outcome was quality of life measured by the Pediatric Asthma Quality of Life Questionnaire, which consists of 3 subscales that measure symptoms (10 items), activity limitations (5 items), and emotional functioning (8 items) in the past 2 weeks. Each item was measured on a 7-point scale, with higher mean scores indicating better quality of life. Secondary measures included the Asthma Control Questionnaire and an asthma self-management index capturing steps to prevent and manage symptoms, self-efficacy, and lung function.
Of 395 eligible adolescents, 35 refused, 38 did not show or were lost to contact, and 2 withdrew before randomization; 320 adolescents participated (mean [SD] age, 14.3 [1.71] years), including 168 boys (52.5%), 251 Black or African American adolescents (78.4%), and 232 adolescents (72.5%) with public health insurance. Of 320 enrolled, 303 were included in the longitudinal analysis. Response rates were 80% or higher at all time points. The peer-led group had greater improvement in outcomes than the adult-led group, with adjusted mean differences (AMDs) between baseline and 15 months of 0.75 vs 0.37 for quality of life (between-group AMD, 0.38; 95% CI, 0.07 to 0.63) and -0.59 vs -0.31 for asthma control (between-group AMD, -0.28; 95% CI, -0.51 to -0.01). Outcomes were not affected by bimonthly contact doses.
In this randomized clinical trial, a peer-led asthma self-management education was more effective than an adult-led program in improving asthma outcomes, with the improvements sustained for up to 15 months. These findings suggest that a peer-led asthma self-management program should be considered in addressing the disproportionate asthma burden in racial and ethnic minority adolescents living in urban communities.
ClinicalTrials.gov Identifier: NCT02293499.
长期以来,同伴主导的哮喘自我管理项目在改善城市地区青少年哮喘结局方面的有效性一直未得到证实。
确定同伴主导的方案对主要为不同种族和族裔的城市青少年的哮喘控制、生活质量和哮喘管理的长期影响。
设计、地点和参与者:这是一项 2015 年至 2019 年在美国 3 个大都市进行的平行组随机临床试验:纽约州布法罗市、马里兰州巴尔的摩市和田纳西州孟菲斯市。招募年龄在 12 至 17 岁之间、持续性哮喘的青少年主要通过临床实践和学校进行。参与者在干预后随访 15 个月。基线实现了双盲。数据分析于 2019 年 6 月至 2020 年 6 月进行。
干预组接受同伴主导的哮喘自我管理方案;对照组接受由成人保健专业人员主导的相同方案。同伴领导者每两个月进行一次随访,持续 12 个月。
主要结局是生活质量,采用儿童哮喘生活质量问卷进行评估,该问卷由 3 个子量表组成,测量过去 2 周的症状(10 项)、活动受限(5 项)和情绪功能(8 项)。每个项目都在 7 点量表上进行测量,平均得分越高表示生活质量越好。次要测量指标包括哮喘控制问卷和哮喘自我管理指数,该指数涵盖预防和管理症状、自我效能和肺功能的步骤。
在 395 名符合条件的青少年中,有 35 人拒绝,38 人未出现或失去联系,2 人在随机分组前退出;320 名青少年参与(平均[标准差]年龄,14.3[1.71]岁),包括 168 名男孩(52.5%)、251 名黑人和非洲裔美国人青少年(78.4%)和 232 名(72.5%)有公共医疗保险的青少年。在 320 名入组的青少年中,有 303 名纳入纵向分析。所有时间点的应答率均在 80%或以上。同伴主导组的结局改善优于成人主导组,与基线相比,15 个月时的生活质量调整平均差异(AMD)为 0.75 分 vs 0.37 分(组间 AMD,0.38 分;95%CI,0.07 分至 0.63 分),哮喘控制的 AMD 为-0.59 分 vs -0.31 分(组间 AMD,-0.28 分;95%CI,-0.51 分至 -0.01 分)。结果不受每两个月接触剂量的影响。
在这项随机临床试验中,同伴主导的哮喘自我管理教育比成人主导的方案更能有效改善哮喘结局,改善可持续长达 15 个月。这些发现表明,应考虑在种族和族裔少数群体青少年居住的城市社区中使用同伴主导的哮喘自我管理方案来解决不成比例的哮喘负担。
ClinicalTrials.gov 标识符:NCT02293499。